OverviewChartNewsTraderScreen

BNP Paribas Knock-Out ALGN/  DE000PC82CZ0  /

Frankfurt Zert./BNP
6/14/2024  12:21:02 PM Chg.+0.040 Bid12:28:18 PM Ask12:28:18 PM Underlying Strike price Expiration date Option type
8.510EUR +0.47% 8.520
Bid Size: 500		 8.820
Ask Size: 500		 Align Technology Inc 360.6064 USD 12/31/2078 Put
GlobeNewswire 12:32 PM UPDATE - Closing Ceremony of the 1st China (Shenyang) Comedy Film Week and the Comedy Film Festival ...
GlobeNewswire 12:00 PM Five Historic Properties, Formerly Held by Caltrans, Coming Back on the Market in South Pasadena wit...
GlobeNewswire 12:00 PM Greenwich LifeSciences Announces $2.5 Million Private Placement
GlobeNewswire 12:00 PM The Ensign Group, Inc. Declares Quarterly Dividend of $0.06 Per Share
GlobeNewswire 12:00 PM Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Tria...
Newsfile Corp 11:31 AM NETA Auto Announces Over 30,000 Orders Within 35 Days Since Launch
Newsfile Corp 11:30 AM Research from Hellotickets Reveals the Best and Worst Travel Destinations in Europe for Hayfever Suf...
Newsfile Corp 11:23 AM BabyBonk (BABYBONK) Is Now Available for Tranding on LBank Exchange
Newsfile Corp 10:54 AM Speech and More Launches Comprehensive Speech Therapy Services Across Australia
GlobeNewswire 9:15 AM HSBC Bank plc: Post Stabilisation Notice
GlobeNewswire 9:11 AM Early Signals by WOO X: BTC Faces Downward Trend While TON Ecosystem Reaches New Highs with Surging ...
GlobeNewswire 9:05 AM Zefiro Publishes “Letter from the CEO” Following its Inaugural Earnings Report
GlobeNewswire 9:01 AM Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients ...
GlobeNewswire 9:00 AM Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investi...
GlobeNewswire 9:00 AM Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patie...
GlobeNewswire 9:00 AM Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimila...
GlobeNewswire 8:00 AM Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ T...
GlobeNewswire 7:30 AM Azerion initiates a Written Procedure and launches a Subsequent Bond Issue
GlobeNewswire 7:22 AM Flash News: OKX Wallet Now Integrated with DragonSwap
GlobeNewswire 7:00 AM WISeKey Announces Retirement of Peter Ward as Chief Financial Officer; Appoints John O’Hara as its N...
GlobeNewswire 6:36 AM Flash News: OKX to Adjust Several Futures' Position Tiers
GlobeNewswire 6:12 AM Flash News: OKX Lists Aethir's ATH Token on its Perpetual Futures Market
GlobeNewswire 5:30 AM Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded Warrants
GlobeNewswire 3:00 AM Gain Therapeutics Announces Pricing of $11.0 Million Public Offering
GlobeNewswire 3:00 AM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...